With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through our nearly 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Tumor cell hybridoma vaccine for recurrent neuroblastoma and Ewing sarcoma||The Pennsylvania State University / Ken Lucas, MD||Innovation Grants||2006||Pennsylvania|
|Tyrosine Kinase Mutation Discovery in Neuroblastoma.||Dana-Farber Cancer Institute / Matthew Meyerson, MD, PhD||Innovation Grants||2006||Massachusetts|
|Molecular characterization of OTX2 as a novel therapeutic target.||Duke University Medical Center / Hai Yan, MD||Innovation Grants||2006||North Carolina|
|Parallel sequencing to identify the causes of childhood cancer.||Baylor College of Medicine / Sharon Plon, MD, PhD||Innovation Grants||2006||Texas|
|HMG-I/Y in pediatric Leukemia and Lymphoma.||The Johns Hopkins University School of Medicine / Linda Smith Resar, MD||Innovation Grants||2006||Maryland|
|Targeting Pediatric Brainstem Glioma with Oncolytic Polioviruses.||Duke University Medical Center / Matthias Gromeier, MD||Innovation Grants||2006||North Carolina|
|Anti-Angiogenic (Metronomic) Chemotherapy in Children with Poor Prognosis.||Dana-Farber Cancer Institute / Mark Kieran, MD, PhD||Innovation Grants||2006||Massachusetts|
|CHOA Experimental Therapy Pediatric Oncology Research.||Aflac Cancer Center and Blood Disorders Service of Children's Healthcare of Atlanta / Howard Katzenstein, MD||Phase I/II Infrastructure Grants||2006||Georgia|
|Expanding Access to New Agents for Cancer Treatment.||Children's Hospital Colorado / Lia Gore, MD||Phase I/II Infrastructure Grants||2006||Colorado|
|Use sophisticated approaches to optimize the effectiveness of current chemotherapy agents, and to develop novel chemotherapy agents||Seattle Children's Hospital and Regional Medical Center / Julie Park, MD||Phase I/II Infrastructure Grants||2006||Washington|